YZ8-20111-00178
4 vaccinations
6 coded responses
39 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 190 / PA
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
LT3-21167-36649
Child or adolescent in my care · Female · 2022-12-11
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Pfizer-BioNTech
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Throat irritation — Feeling: GoodFree text: Scratchy throat mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-12
- 2021-01-13
- 2021-01-20
- 2021-01-27
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Survey response — day 21, dose 2MedDRA: Headache, Respiratory tract congestion — Feeling: GoodFree text: HeadachesCongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-28
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2021-12-10
Dose 3 — Pfizer-BioNTech
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-12-10
Dose 4 — Pfizer-BioNTech
-
2022-12-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-12
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-12-13
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-12-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2022-12-15
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
- 2022-12-16
- 2022-12-17
- 2022-12-24
-
2022-12-31
Survey response — day 21, dose 4MedDRA: Sinusitis — Feeling: Fair · Be unable to work or attend schoolFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
- 2023-01-07
- 2023-01-15
-
2023-01-21
Survey response — day 42, dose 4MedDRA: Norovirus infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-03-11
- 2023-06-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-12-10 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Scratchy throat mild
Release 4 — day 21, dose 2
Symptoms: HeadachesCongestion
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Release 12 — day 21, dose 4
Symptoms: Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Norovirus infection | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Throat irritation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release